Home » Stocks » PURE

PURE Bioscience Inc. (PURE)

Stock Price: $1.06 USD -0.07 (-6.20%)
Updated November 27, 12:59 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 92.30M
Revenue (ttm) 6.92M
Net Income (ttm) 4,000
Shares Out 87.07M
EPS (ttm) 0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $1.06
Previous Close $1.13
Change ($) -0.07
Change (%) -6.20%
Day's Open 1.13
Day's Range 1.06 - 1.13
Day's Volume 15,739
52-Week Range 0.26 - 2.01

More Stats

Market Cap 92.30M
Enterprise Value 88.38M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 87.07M
Float n/a
EPS (basic) n/a
EPS (diluted) 0.00
FCF / Share 0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.66%
Payout Ratio n/a
Shares Short 222,969
Short Ratio 2.56
Short % of Float n/a
Beta 0.17
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 151.06
PS Ratio 13.34
PB Ratio 22.44
Revenue 6.92M
Operating Income 4,000
Net Income 4,000
Free Cash Flow 611,000
Net Cash 3.91M
Net Cash / Share 0.04
Gross Margin 58.13%
Operating Margin 0.06%
Profit Margin 0.10%
FCF Margin 8.83%
ROA 0.06%
ROE 0.13%
ROIC 3.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $1.06
Target: 24.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth262.34%7.61%-3.11%42.05%76.82%32.55%-32.93%0.99%75%-
Gross Profit4.
Operating Income--5.59-7.04-6.01-7.06-7.64-11.90-7.34-8.75-8.37
Net Income--6.55-7.44-6.26-14.37-7.63-11.05-7.67-8.89-8.35
Shares Outstanding82.2172.8867.2863.4956.8339.7525.6110.845.624.67
Earnings Per Share--0.09-0.11-0.10-0.25-0.19-0.43-0.71-1.58-1.79
Operating Cash Flow0.67-2.99-3.89-4.56-4.99-6.06-6.33-3.90-5.59-6.12
Capital Expenditures-0.06-0.01-0.02-0.21-0.39-0.080.05-0.01-0.01-0.01
Free Cash Flow0.61-3.00-3.91-4.77-5.38-6.14-6.28-3.92-5.60-6.14
Cash & Equivalents3.910.470.931.725.271.400.090.030.881.79
Total Debt--0.50----1.26--
Net Cash / Debt3.910.470.421.725.271.400.09-1.220.881.79
Book Value4.811.
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PURE Bioscience Inc.
Country United States
Employees 10
CEO Tom Y. Lee

Stock Information

Ticker Symbol PURE
Stock Exchange US OTC
Sector Consumer Defensive
Industry Household & Personal Products
Unique Identifier OTCMKTS: PURE
IPO Date August 8, 1996


PURE Bioscience develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. It also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. The company was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.